A carregar...
Efficacy and safety of a new intravenous immunoglobulin (Panzyga(®)) in chronic immune thrombocytopenia
OBJECTIVES: To assess the efficacy and safety of intravenous immunoglobulin (IVIG) 10% (Panzyga(®)), a novel human normal IVIG 10%, in patients with chronic immune thrombocytopenia (ITP). BACKGROUND: First‐line treatment options in ITP include IVIGs. METHODS: In this prospective, open‐label, non‐con...
Na minha lista:
| Publicado no: | Transfus Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6850321/ https://ncbi.nlm.nih.gov/pubmed/30687970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tme.12573 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|